Freiburg, May 7th, 2025 Study results demonstrate superiority of norucholic acid (NCA) over placebo in the combined primary endpoint. There is currently no approved medicine to treat primary sclerosing cholangitis. The results of the 96-week analysis of the NUC-5 trial will be presented at 2025 EASL Congress in Amsterdam. Dr. Falk Pharma, a research-based pharmaceutical […]
Read more
Related Articles
مستقبل السفر يبدأ الآن: فعالية SOUEAST العالمية لتجربة التكنولوجيا لعام 2026 تنطلق قريبًا
مدينة ووهو, Oct. 13, 2026 (GLOBE NEWSWIRE) — تحت شعار “مستقبل السفر يبدأ الآن”، تنطلق فعالية SOUEAST العالمية لتجربة التكنولوجيا لعام 2026 في 20 أكتوبر/تشرين الأول. وانطلاقًا من استراتيجيتها “Travel+”، ستعرض SOUEAST تقنياتها الهجينة ومزايا منتجاتها، مجسّدةً رسالة علامتها التجارية “EASE YOUR LIFE” من خلال تجارب سفر واقعية. وبمشاركة ممثلين عن وسائل الإعلام والمؤثرين والمستخدمين […]
Coventry Signals Next Phase of Longevity-Linked ABS Development at SFVegas
FORT WASHINGTON, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) — Coventry, the leader and creator of the secondary market for life insurance and a pioneer of the life insurance-backed asset class, will attend SFVegas® 2026 to engage with structured finance leaders as the institutional market for longevity-linked asset-backed securities continues to mature. Through its LILY platform, […]
Two Hong Kong Restaurants Achieve Top 3 Status in Asia’s 50 Best Restaurants 2025
Together with No.1 Ranking at Asia’s 50 Best Bars, Hong Kong Shines as a Culinary Powerhouse Celebrated chefs from Hong Kong who made it to the 50 Best Restaurants Celebrated chefs from Hong Kong who made it to the list of Asia’s 50 Best Restaurants 2025, with The Chairman and WING ranked 2nd and 3rd on the […]
